capecitabine

You have access
A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer –ACTOR Study–
MITSUKUNI SUENAGA, TAKASHI AKIYOSHI, EIJI SHINOZAKI, YOSHIYA FUJIMOTO, SATOSHI MATSUSAKA, TSUYOSHI KONISHI, SATOSHI NAGAYAMA, YOSUKE FUKUNAGA, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, TAKAHITO SUGISAKI, MASASHI UENO and TOSHIHARU YAMAGUCHI

Anticancer Research March 2018, 38 (3) 1741-1747;
You have access
Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer
HIRONAGA SATAKE, MASATO KONDO, MOTOKO MIZUMOTO, TAKESHI KOTAKE, YOSHIHIRO OKITA, TAKATSUGU OGATA, YUKIMASA HATACHI, HISATERU YASUI, AKIRA MIKI, YUKIHIRO IMAI, CHIHIRO ICHIKAWA, KENTA MUROTANI, MASAHITO KOTAKA, TAKESHI KATO, SATOSHI KAIHARA and AKIHITO TSUJI

Anticancer Research July 2017, 37 (7) 3703-3710;
You have access
Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence – A Phase II Study
WOLFGANG EISTERER, GUDRUN PIRINGER, ALEXANDER DE VRIES, DIETMAR ÖFNER, RICHARD GREIL, JÖRG TSCHMELITSCH, HELLMUT SAMONIGG, LIDIJA SÖLKNER, MICHAEL GNANT, JOSEF THALER and On behalf of the Austrian Breast and Colorectal Cancer Study Group

Anticancer Research May 2017, 37 (5) 2683-2691;
You have access
A Comparative Effectiveness Study of Two Oral Chemotherapy Drugs (UFT vs. Capecitabine) in Neoadjuvant Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer
CHUN-RU CHIEN, WILLIAM TZU-LIANG CHEN, HWEI-MIN WANG, TAO-WEI KE, HUA-CHE CHIANG, SHENG-CHI CHANG, YU-CHUN HUANG, CHE-HUNG LIN, CHUN-LIN HUANG, YING-CHUN LIN, TSUNG-WEI CHEN, CHIA-CHIN LI and K.S. CLIFFORD CHAO

Anticancer Research November 2016, 36 (11) 6155-6160;
You have access
Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients
VERONIKA RACHAR, MARTIN CZEJKA, MARIE KITZMUELLER, PHILIPP BUCHNER, MARIA LICHTNECKERT, RICHARD GREIL, HERBERT GEILER and CHRISTIAN DITTRICH

Anticancer Research September 2016, 36 (9) 4715-4723;
You have access
Mitomycin C and Capecitabine (MiX Trial) for Therapy of Patients with Metastasized, Breast Cancer Pretreated with Anthracycline
KATRIN ALMSTEDT, PETER A. FASCHING, ANTON SCHARL, CLAUDIA RAUH, BRIGITTE RACK, ALEXANDER HEIN, CAROLIN C. HACK, CHRISTIAN M. BAYER, SEBASTIAN M. JUD, MICHAEL G. SCHRAUDER, MATTHIAS W. BECKMANN and MICHAEL P. LUX

Anticancer Research January 2016, 36 (1) 419-425;
You have access
5-Fluorouracil Chemotherapy for Dihydropyrimidine Dehydrogenase-deficient Patients: Potential of the Dose-escalation Method
YOICHIRO YOSHIDA, KENICHIRO OGURA, AKIRA HIRATSUKA, NAOYA AISU, TEPPEI YAMADA, DAIBO KOJIMA, SYU TANIMURA, KENTARO OGATA, SHUUJI HARA, AI MOGI, YASUSHI TAKAMATSU, KAZUO TAMURA, HIDEYUKI MISHIMA and YUICHI YAMASHITA

Anticancer Research September 2015, 35 (9) 4881-4887;
You have access
Concomitant Capecitabine with Hepatic Delivery of Drug Eluting Beads in Metastatic Colorectal Cancer
OLAGUOKE AKINWANDE, AMANDA MILLER, DAVID HAYES, RYAN O'HARA, DANA TOMALTY and ROBERT C.G. MARTIN

Anticancer Research December 2014, 34 (12) 7239-7245;
You have access
Preoperative Treatment with Capecitabine, Cetuximab and Radiotherapy for Primary Locally Advanced Rectal Cancer – A Phase II Clinical Trial
WOLFGANG EISTERER, ALEXANDER DE VRIES, DIETMAR ÖFNER, HANS RABL, RENATE KOPLMÜLLER, RICHARD GREIL, JÖERG TSCHMELITSCH, RAINER SCHMID, KARIN KAPP, PETER LUKAS, FELIX SEDLMAYER, GERALD HÖFLER, MICHAEL GNANT, JOSEF THALER and on behalf of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)

Anticancer Research November 2014, 34 (11) 6767-6773;
You have access
Immunohistochemical Features Associated with Sensitivity to Lapatinib-plus-Capecitabine and Resistance to Trastuzumab in HER2-positive Breast Cancer
YONGJUN CHA, SAE-WON HAN, HYESIL SEOL, DO-YOUN OH, SEOCK-AH IM, YUNG-JUE BANG, IN AE PARK, WONSHIK HAN, DONG-YOUNG NOH and TAE-YOU KIM

Anticancer Research August 2014, 34 (8) 4275-4280;

Main menu

User menu

Search

capecitabine

Pages